ATXI Stock Outstanding Shares
Making an investment decision in the stock market involves a certain amount of risk, so it's important to thoroughly review a company's stock before making any decisions. Stock float, number of short positions and outstanding shares are among the many factors an investor should take into account.
ShortableYes
OptionableNo
Short Percent Of Outstanding Shares3.56
Short Percent Of Float3.56
Shares Outstanding2.05M
Shares Float1.29M
Shares Short50.92K
Short Ratio0.73
3.56%
Short % of Float3.56%
Short % of Shares OutstandingMarket Insider ATXI
Investors cannot turn a blind eye to insiders as well as institutional ownership. They need to follow insider trades to determine the direction the stock is likely to take.
Major Holders Summary
25.23% Percentage of Shares held by All Insiders
15.33% Percentage of Shares held by All Institutions
20.5% Percentage of Float held by Institutions
9
Number of Institutions Holding SharesInstitutional Ownership
About 15.33% of ATXI shares are held by financial institutions. SHIKIAR ASSET MANAGEMENT INC is the top corporate investor, holding 25K shares valued at $29.00K. A 1.12% stake in Avenue Therapeutics, Inc. is owned by the company. ICON WEALTH PARTNERS, LLC owns 0 shares valued at -, which translates its holding of 0% of the stake in the company.
ATXI Insiders
Among the ATXI insiders holding of 25.23% of the stake in company, FORTRESS BIOTECH, INC., 10 percent owner, holds the largest shares of 1.03M. ROSENWALD LINDSAY A MD, director, is the second largest ATXI insider with ownership of 354.32K shares. PALEY JEFFREY, director, stands third with possession of 79.66K shares of that stake.
Buying/Selling by Insiders
Insider Transaction Summary (6 Months)
SHARESTRANS
PURCHASE5002
SALES842
NET SHARES4160
NO. OF SHARES HELD1.4K4
% NET SHARES-70.26%-100%
Frequently Asked Questions
How many institutions own ATXI stock?
A company's 13F filings with the Securities and Exchange Commission (SEC) provides investors with comprehensive information about institutional ownership in a listed company, a sign of strength in terms of how many institutions have confidence in that company. The number of institutional investors who currently own ATXI shares is 9, representing 15.33% of the company's common stock.
Who are the major shareholders selling Avenue Therapeutics, Inc. stock?
ICON WEALTH PARTNERS, LLC, in the last quarter, reduced its stake in ATXI by -100% restricting it's holding to 0 shares of worth nearly -. N/A also lessened N/A of the ATXI shares from its portfolio, reducing its holding to - shares of worth -. N/A also shunned ATXI shares holding by N/A last quarter which brought its holding to - shares worth -.
Investors who are buying ATXI stock?
As per its latest 13F filing, SHIKIAR ASSET MANAGEMENT INC increased its stake in ATXI by 100% in the last quarter. The institutional holder raised its holding to 25 thousand shares having worth more than $29.00K. N/A also added N/A more shares of ATXI to its portfolio, raising its holding to - shares of worth -. N/A also increased its ATXI shares holding by N/A which brought its holding to - shares worth -.
ATXI's major insiders: who are they?
The insider with the most stakes in ATXI is Fortress Biotech, Inc. , 10 percent owner at the company. Additionally, ATXI stock is highly held by director ROSENWALD LINDSAY A MD and director Paley Jeffrey among others.
Did an insider recently sell ATXI stock?
Company executives, directors, and other insiders own 25.23% percent of Avenue Therapeutics, Inc.'s stock. Within the last six months, there have been 2 transaction(s) in which ATXI insiders have sold stock, totaling 84 shares. Insiders that have sold shares include HERSKOWITZ NEIL, KRANZLER JAY D, and DAVIDOW ROBERT L.
Which insider recently purchased ATXI stock?
There have been 2 transaction(s) during the past 6-months in which Avenue Therapeutics, Inc. insiders have bought stock, totalling 500 shares
How much of ATXI does insiders own?
Around 1.4K Avenue Therapeutics, Inc. shares are held by insiders, which represents about 25.23% of ATXI stock.
Who is the insider with the largest stake?
ATXI 10 percent owner, Fortress Biotech, Inc. holds the largest portfolio of the company's shares. ATXI shares owned by Fortress total nearly 1.03 million.
Which institution holds the most shares in ATXI?
SHIKIAR ASSET MANAGEMENT INC is the largest institutional owner in ATXI which holds 25 thousand shares worth $29.00K or 1.12% of the total ATXI shares outstanding followed by ICON WEALTH PARTNERS, LLC with ownership of 0 shares representing 0% of the ATXI ownership. N/A is the third largest stakeholder with - shares or N/A of the ownership worth more than -.
Is Avenue Therapeutics, Inc. stock optionable?
Stock options give the owner the ability but not the obligation to buy or sell a security at a predetermined price and date. Stock options can be classified into two types: puts and calls. A put is a bet on falling stock, and a call is a bet on rising stock. As far as the ATXI is concerned, it is a stock which is not optionable.
Is there a short position on ATXI's shares?
Number of ATXI shares short is 50.92K. Shares short is a market sentiment in which investors have sold their shares short in a given stock but have not yet covered them or closed them out.
About how many outstanding ATXI shares are there?
As of today, 2.05M shares of ATXI are outstanding.
Is there many float in ATXI stock?
Float represents the number of tradeable shares in a specific stock. By subtracting restricted and closely-held shares from a firm's total outstanding shares, we can calculate its floating stock. The term "closely-held shares" refers to shares held by employees, major shareholders, and company insiders. At present, ATXI has 1.29M shares in float.
ATXI short ratio: what is it?
Short ratio is calculated by dividing the number of short shares, short interest or bets that shareholders will sell short from the average daily volume. A higher ratio indicates longer times needed to repurchase borrowed shares (sold). The short ratio for ATXI is 0.73.